Trial Profile
A Study to Evaluate the Impact of Disease Status and Type of Relapse on Outcome in Relapsed/Refractory Multiple Myeloma (RRMM) Patients Treated With Lenalidomide Combined With Dexamethasone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2016
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Apr 2016 New trial record